SteadyMed Ltd. (NASDAQ:STDY) Scheduled to Post Quarterly Earnings on Monday

SteadyMed Ltd. (NASDAQ:STDY) is scheduled to be posting its 6/30/2017 quarterly earnings results before the market opens on Monday, August 14th. Analysts expect SteadyMed to post earnings of ($0.32) per share for the quarter.

SteadyMed Ltd. (NASDAQ STDY) opened at 6.20 on Friday. The firm’s market capitalization is $156.06 million. SteadyMed Ltd. has a 52-week low of $2.25 and a 52-week high of $9.70. The stock’s 50 day moving average price is $6.35 and its 200 day moving average price is $5.58.

Separately, Zacks Investment Research downgraded SteadyMed from a “hold” rating to a “sell” rating in a research report on Tuesday, June 6th.

ILLEGAL ACTIVITY WARNING: This news story was originally published by Community Financial News and is the sole property of of Community Financial News. If you are reading this news story on another domain, it was copied illegally and reposted in violation of U.S. & international copyright & trademark legislation. The legal version of this news story can be read at https://www.com-unik.info/2017/08/12/steadymed-ltd-nasdaqstdy-scheduled-to-post-quarterly-earnings-on-monday.html.

About SteadyMed

SteadyMed Ltd. is a specialty pharmaceutical company. The Company is focused on the development and commercialization of various therapeutic product candidates. Its primary focus is to obtain approval in the United States for the sale of Trevyent for the treatment of pulmonary arterial hypertension (PAH).

Earnings History for SteadyMed (NASDAQ:STDY)

What are top analysts saying about SteadyMed Ltd.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for SteadyMed Ltd. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit